Obstructive Sleep Apnea is Common and Associated with Heart Remodeling in Patients with Chagas Disease
- PMID: 30088557
- PMCID: PMC6173344
- DOI: 10.5935/abc.20180131
Obstructive Sleep Apnea is Common and Associated with Heart Remodeling in Patients with Chagas Disease
Abstract
Background: Chagas Disease (CD) is an important cause of morbimortality due to heart failure and malignant arrhythmias worldwide, especially in Latin America.
Objective: To investigate the association of obstructive sleep apnea (OSA) with heart remodeling and cardiac arrhythmias in patients CD.
Methods: Consecutive patients with CD, aged between 30 to 65 years old were enrolled. Participants underwent clinical evaluation, sleep study, 24-hour Holter monitoring, echocardiogram and ambulatory blood pressure monitoring.
Results: We evaluated 135 patients [age: 56 (45-62) years; 30% men; BMI: 26 ± 4 kg/m2, Chagas cardiomyopathy: 70%]. Moderate to severe OSA (apnea-hypopnea index, AHI, ≥ 15 events/h) was present in 21% of the patients. OSA was not associated with arrhythmias in this population. As compared to patients with mild or no OSA, patients with moderate to severe OSA had higher frequency of hypertension (79% vs. 72% vs. 44%, p < 0.01) higher nocturnal systolic blood pressure: 119 ± 17 vs. 113 ± 13 vs. 110 ± 11 mmHg, p = 0.01; larger left atrial diameter [37 (33-42) vs. 35 (33-39) vs. 33 (30-36) mm, p < 0.01]; and a greater proportion of left ventricular dysfunction [LVEF < 50% (39% vs. 28% vs. 11%), p < 0.01], respectively. Predictor of left atrial dimension was Log10 (AHI) (b = 3.86, 95% CI: 1.91 to 5.81; p < 0.01). Predictors of ventricular dysfunction were AHI > 15 events/h (OR = 3.61, 95% CI: 1.31 - 9.98; p = 0.01), systolic blood pressure (OR = 1.06, 95% CI: 1.02 - 1.10; p < 0.01) and male gender (OR = 3.24, 95% CI: 1.31 - 8.01; p = 0.01).
Conclusions: OSA is independently associated with atrial and ventricular remodeling in patients with CD.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Comment in
-
Obstructive Sleep Apnea: A Marker of Cardiac Remodeling in Patients with Chronic Chagas Disease.Arq Bras Cardiol. 2018 Sep;111(3):373-374. doi: 10.5935/abc.20180177. Arq Bras Cardiol. 2018. PMID: 30379255 Free PMC article. No abstract available.
Similar articles
-
Twenty-four hour Blood Pressure in Obese Patients with Moderate-to-Severe Obstructive Sleep Apnea.Arq Bras Cardiol. 2017 Oct;109(4):313-320. doi: 10.5935/abc.20170130. Epub 2017 Sep 4. Arq Bras Cardiol. 2017. PMID: 28876375 Free PMC article.
-
Nocturnal hypoxia indexes are associated with left ventricular remodeling and diastolic dysfunction in obstructive sleep apnea patients.Sleep Med. 2023 Mar;103:180-186. doi: 10.1016/j.sleep.2023.02.004. Epub 2023 Feb 10. Sleep Med. 2023. PMID: 36812862
-
Severe obstructive sleep apnea increases left atrial volume independently of left ventricular diastolic impairment.Sleep Breath. 2015 Dec;19(4):1249-55. doi: 10.1007/s11325-015-1153-7. Epub 2015 Mar 17. Sleep Breath. 2015. PMID: 25778947
-
Predictive echocardiographic factors of severe obstructive sleep apnea.Pan Afr Med J. 2021 Apr 14;38:359. doi: 10.11604/pamj.2021.38.359.28470. eCollection 2021. Pan Afr Med J. 2021. PMID: 34367438 Free PMC article.
-
Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy.Chest. 2010 May;137(5):1078-84. doi: 10.1378/chest.09-2335. Epub 2010 Feb 12. Chest. 2010. PMID: 20154076
Cited by
-
Lower Prevalence and Severity of Coronary Atherosclerosis in Chronic Chagas' Disease by Coronary Computed Tomography Angiography.Arq Bras Cardiol. 2020 Dec;115(6):1051-1060. doi: 10.36660/abc.20200342. Arq Bras Cardiol. 2020. PMID: 33470300 Free PMC article. English, Portuguese.
-
Obstructive Sleep Apnea: A Marker of Cardiac Remodeling in Patients with Chronic Chagas Disease.Arq Bras Cardiol. 2018 Sep;111(3):373-374. doi: 10.5935/abc.20180177. Arq Bras Cardiol. 2018. PMID: 30379255 Free PMC article. No abstract available.
References
-
- World Health Organization Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015;(6):33–44. - PubMed
-
- World Health Organization . Research priorities for Chagas Disease, human african trypanosomiasis and leishmaniasis: technical report of the TDR disease reference group on Chagas Disease, Human African Trypanosomiasis and Leishmaniasis. Genebra: Suiça; 2012. - PubMed
-
- Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. Sociedade Brasileira de Cardiologia Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy. Arq Bras Cardiol. 2011;97(2) Suppl 3:1–48. - PubMed
-
- Albajar-Vinas P, Jannin J. Chagas disease in Europe. Eurosurveillance. 2011 Sep 22;16(38) special edition. - PubMed
-
- Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Jr, Rosas F, BENEFIT Investigators et al. Randomized trial of benznidazole for chronic Chagas' cardiomyopathy. N Engl J Med. 2015;373(14):1295–1306. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials